• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性肺纤维化患者肺动脉高压的发病率及临床特征

Incidence and clinical characteristics of pulmonary hypertension in patients with idiopathic pulmonary fibrosis.

作者信息

Yan Wei, Peng Li-Ying, Ban Cheng-Jun, Xu Xue-Feng, Zhu Min, Liu Yan, Zhang Shu, Zhai Zhen-Guo, Wang Chen, Dai Hua-Ping

机构信息

Department of Respiratory and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University; Beijing Key Laboratory of Respiratory and Pulmonary Circulation, Beijing Institute of Respiratory Medicine, Beijing 100020, China.

出版信息

Chin Med J (Engl). 2015 Apr 5;128(7):896-901. doi: 10.4103/0366-6999.154284.

DOI:10.4103/0366-6999.154284
PMID:25836609
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4834005/
Abstract

BACKGROUND

Pulmonary hypertension (PH) frequently complicates the course of idiopathic pulmonary fibrosis (IPF) patients and is associated with significantly worse outcomes. The aim of the present study was to investigate the incidence of PH in IPF patients and evaluate the correlation between clinical parameters and systolic pulmonary artery pressure (sPAP).

METHODS

Hospitalized patients with IPF, who were evaluated for sPAP by Doppler echocardiography from January 2004 to December 2011, were enrolled in our study. Patients were defined as PH by an estimated sPAP > 50 mmHg and graded as PH likely, PH possible and PH unlikely, based on the 2009 European Society of Cardiology/European Respiratory Society PH Guidelines. The correlations between clinical parameters and sPAP were analyzed by multiple linear regression.

RESULTS

Totally, 119 IPF patients were enrolled in our study and 28 (23.5%), 20 (16.8%) and 71 (59.7%) patients were PH likely, PH possible and PH unlikely, respectively. Borg dyspnea score was positively correlated with sPAP, r = 0.467, P < 0.001. Oxygen saturation was negatively correlated with sPAP, r = -0.416, P < 0.001. Diffusing capacity of the lung for carbon monoxide percentage predicted was negatively correlated with sPAP, r = -0.424, P = 0.003. N-terminal fragment of pro-brain natriuretic peptide and pulmonary artery width was positively correlated with sPAP, r = 0.452, P = 0.011 and r = 0.513, P < 0.001, respectively.

CONCLUSIONS

The incidence of PH in IPF patients was 23.5% in a single center of China. PH may worsen the dyspnea, right heart dysfunction and decrease the life quality of the patients with IPF.

摘要

背景

肺动脉高压(PH)常使特发性肺纤维化(IPF)患者病情复杂化,并与显著更差的预后相关。本研究的目的是调查IPF患者中PH的发生率,并评估临床参数与收缩期肺动脉压(sPAP)之间的相关性。

方法

纳入2004年1月至2011年12月期间因IPF住院且通过多普勒超声心动图评估sPAP的患者。根据2009年欧洲心脏病学会/欧洲呼吸学会PH指南,估计sPAP>50 mmHg的患者被定义为PH,并分为可能PH、疑似PH和不太可能PH。通过多元线性回归分析临床参数与sPAP之间的相关性。

结果

本研究共纳入119例IPF患者,其中可能PH、疑似PH和不太可能PH的患者分别为28例(23.5%)、20例(16.8%)和71例(59.7%)。Borg呼吸困难评分与sPAP呈正相关,r = 0.467,P < 0.001。氧饱和度与sPAP呈负相关,r = -0.416,P < 0.001。预测的一氧化碳弥散量百分比与sPAP呈负相关,r = -0.424,P = 0.003。脑钠肽前体N端片段和肺动脉宽度与sPAP呈正相关,r分别为0.452,P = 0.011和r = 0.513,P < 0.001。

结论

在中国的一个单中心,IPF患者中PH的发生率为23.5%。PH可能会加重IPF患者的呼吸困难、右心功能不全并降低其生活质量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5cc/4834005/0280fe0240b4/CMJ-128-896-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5cc/4834005/ae9d6ee20209/CMJ-128-896-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5cc/4834005/0280fe0240b4/CMJ-128-896-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5cc/4834005/ae9d6ee20209/CMJ-128-896-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5cc/4834005/0280fe0240b4/CMJ-128-896-g002.jpg

相似文献

1
Incidence and clinical characteristics of pulmonary hypertension in patients with idiopathic pulmonary fibrosis.特发性肺纤维化患者肺动脉高压的发病率及临床特征
Chin Med J (Engl). 2015 Apr 5;128(7):896-901. doi: 10.4103/0366-6999.154284.
2
Exercise capacity in idiopathic pulmonary fibrosis: the effect of pulmonary hypertension.特发性肺纤维化患者的运动能力:肺动脉高压的影响。
Respirology. 2011 Apr;16(3):451-8. doi: 10.1111/j.1440-1843.2010.01909.x.
3
Pulmonary hypertension in idiopathic pulmonary fibrosis: prevalence and clinical progress.特发性肺纤维化中的肺动脉高压:患病率和临床进展。
Int J Immunopathol Pharmacol. 2012 Jul-Sep;25(3):681-9. doi: 10.1177/039463201202500314.
4
Prevalence of pulmonary hypertension in patients with idiopathic pulmonary fibrosis: correlation with physiological parameters.特发性肺纤维化患者肺动脉高压的患病率:与生理参数的相关性。
Lung. 2011 Oct;189(5):391-9. doi: 10.1007/s00408-011-9304-5. Epub 2011 Jun 11.
5
Pulmonary hypertension in chronic lung diseases.慢性肺部疾病相关肺动脉高压。
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D109-16. doi: 10.1016/j.jacc.2013.10.036.
6
Pulmonary hypertension in patients with idiopathic pulmonary fibrosis.特发性肺纤维化患者的肺动脉高压
Chest. 2005 Oct;128(4):2393-9. doi: 10.1378/chest.128.4.2393.
7
Effects of oxygen on exercise-induced increase of pulmonary arterial pressure in idiopathic pulmonary fibrosis.氧对特发性肺纤维化运动诱导的肺动脉压升高的影响。
Sarcoidosis Vasc Diffuse Lung Dis. 2008 Dec;25(2):133-9.
8
Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis.特发性肺纤维化初始评估中肺动脉高压作为预后指标。
Respiration. 2013;85(6):456-63. doi: 10.1159/000345221. Epub 2012 Dec 19.
9
Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis.结节病患者肺动脉高压的发病率及其临床相关性。
Chest. 2006 May;129(5):1246-52. doi: 10.1378/chest.129.5.1246.
10
Pulmonary hypertension in idiopathic pulmonary fibrosis: a review.特发性肺纤维化中的肺动脉高压:综述。
Respiration. 2011;82(3):294-304. doi: 10.1159/000327918. Epub 2011 Jun 15.

引用本文的文献

1
Mental health burden in progressive pulmonary fibrosis and idiopathic pulmonary fibrosis: Depression and anxiety.进行性肺纤维化和特发性肺纤维化中的心理健康负担:抑郁和焦虑
Sarcoidosis Vasc Diffuse Lung Dis. 2025 Jun 25;42(2):16342. doi: 10.36141/svdld.v42i2.16342.
2
Health-related quality of life in a multiracial Asian interstitial lung disease cohort.一个多民族亚洲间质性肺疾病队列中的健康相关生活质量
J Thorac Dis. 2022 Dec;14(12):4713-4724. doi: 10.21037/jtd-22-906.
3
Echocardiographic characteristics of patients with antisynthetase syndrome.

本文引用的文献

1
Clinical features and outcomes of 210 patients with idiopathic pulmonary fibrosis.210例特发性肺纤维化患者的临床特征与预后
Chin Med J (Engl). 2014;127(10):1868-73.
2
Echocardiographic and hemodynamic predictors of mortality in idiopathic pulmonary fibrosis.特发性肺纤维化患者死亡的超声心动图和血流动力学预测因素。
Chest. 2013 Aug;144(2):564-570. doi: 10.1378/chest.12-2298.
3
Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis.特发性肺纤维化初始评估中肺动脉高压作为预后指标。
抗合成酶综合征患者的超声心动图特征
Pulm Circ. 2022 Apr 27;12(2):e12084. doi: 10.1002/pul2.12084. eCollection 2022 Apr.
4
Idiopathic Pulmonary Fibrosis Registry China study (PORTRAY): protocol for a prospective, multicentre registry study.特发性肺纤维化登记中国研究(PORTRAY):一项前瞻性、多中心登记研究方案。
BMJ Open. 2020 Nov 11;10(11):e036809. doi: 10.1136/bmjopen-2020-036809.
5
Idiopathic Pulmonary Fibrosis: A Systemic Disease?特发性肺纤维化:一种全身性疾病?
Chin Med J (Engl). 2017 Sep 5;130(17):2140-2141. doi: 10.4103/0366-6999.213423.
6
Surgical Treatment of Double Outlet Right Ventricle Complicated by Pulmonary Hypertension.右心室双出口合并肺动脉高压的外科治疗
Chin Med J (Engl). 2017 Feb 20;130(4):409-413. doi: 10.4103/0366-6999.199827.
Respiration. 2013;85(6):456-63. doi: 10.1159/000345221. Epub 2012 Dec 19.
4
Effects of inpatient pulmonary rehabilitation in patients with interstitial lung disease.间质性肺疾病患者的住院肺康复治疗效果。
Eur Respir J. 2013 Aug;42(2):444-53. doi: 10.1183/09031936.00081512. Epub 2012 Oct 25.
5
Pulmonary hypertension in idiopathic pulmonary fibrosis: prevalence and clinical progress.特发性肺纤维化中的肺动脉高压:患病率和临床进展。
Int J Immunopathol Pharmacol. 2012 Jul-Sep;25(3):681-9. doi: 10.1177/039463201202500314.
6
B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide in pediatric patients with pulmonary arterial hypertension.B型利钠肽和氨基末端前B型利钠肽在小儿肺动脉高压患者中的研究
Congenit Heart Dis. 2012 May-Jun;7(3):259-67. doi: 10.1111/j.1747-0803.2011.00620.x. Epub 2012 Feb 10.
7
Prevalence of pulmonary hypertension in patients with idiopathic pulmonary fibrosis: correlation with physiological parameters.特发性肺纤维化患者肺动脉高压的患病率:与生理参数的相关性。
Lung. 2011 Oct;189(5):391-9. doi: 10.1007/s00408-011-9304-5. Epub 2011 Jun 11.
8
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.特发性肺纤维化:诊断和管理的循证指南(美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会联合发布)
Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824. doi: 10.1164/rccm.2009-040GL.
9
Diagnostic accuracy of echocardiography for pulmonary hypertension: a systematic review and meta-analysis.超声心动图诊断肺动脉高压的准确性:系统评价和荟萃分析。
Heart. 2011 Apr;97(8):612-22. doi: 10.1136/hrt.2010.212084. Epub 2011 Feb 25.
10
Clinical and prognostic relevance of echocardiographic evaluation of right ventricular geometry in patients with idiopathic pulmonary arterial hypertension.超声心动图评价特发性肺动脉高压患者右心室构型的临床及预后价值。
Am J Cardiol. 2011 Feb 15;107(4):628-32. doi: 10.1016/j.amjcard.2010.10.027. Epub 2010 Dec 22.